Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Acid, Oxalic
2. Aluminum Oxalate
3. Ammonium Oxalate
4. Chromium (2+) Oxalate
5. Chromium (3+) Oxalate (3:2)
6. Chromium Oxalate
7. Diammonium Oxalate
8. Dilithium Oxalate
9. Dipotassium Oxalate
10. Disodium Oxalate
11. Ferric Oxalate
12. Iron (2+) Oxalate (1:1)
13. Iron (3+) Oxalate
14. Iron Oxalate
15. Magnesium Oxalate
16. Magnesium Oxalate (1:1)
17. Manganese (2+) Oxalate (1:1)
18. Monoammonium Oxalate
19. Monohydrogen Monopotassium Oxalate
20. Monopotassium Oxalate
21. Monosodium Oxalate
22. Oxalate, Aluminum
23. Oxalate, Chromium
24. Oxalate, Diammonium
25. Oxalate, Dilithium
26. Oxalate, Dipotassium
27. Oxalate, Disodium
28. Oxalate, Ferric
29. Oxalate, Iron
30. Oxalate, Magnesium
31. Oxalate, Monoammonium
32. Oxalate, Monohydrogen Monopotassium
33. Oxalate, Monopotassium
34. Oxalate, Monosodium
35. Oxalate, Potassium
36. Oxalate, Potassium Chromium
37. Oxalate, Sodium
38. Potassium Chromium Oxalate
39. Potassium Oxalate
40. Potassium Oxalate (2:1)
41. Sodium Oxalate
1. Ethanedioic Acid
2. 144-62-7
3. Aktisal
4. Aquisal
5. Oxalate
6. Oxiric Acid
7. Oxalsaeure
8. Oxaalzuur
9. Kyselina Stavelova
10. Acide Oxalique
11. Acido Ossalico
12. Acidum Oxalicum
13. Caswell No. 625
14. Oxaalzuur [dutch]
15. Oxalsaeure [german]
16. Oxalicacid
17. Nci-c55209
18. Ethanedionic Acid
19. Acide Oxalique [french]
20. Ethane-1,2-dioic Acid
21. Acido Ossalico [italian]
22. Kyselina Stavelova [czech]
23. Ccris 1454
24. Epa Pesticide Chemical Code 009601
25. Hsdb 1100
26. Ai3-26463
27. Nsc 62774
28. Brn 0385686
29. Hooccooh
30. Oxalic Acid Anhydrous
31. Mfcd00002573
32. Chebi:16995
33. 9e7r5l6h31
34. C2-beta-polymorph
35. Nsc-62774
36. Ethanedioic Acid Dihydrate
37. Ethanedioic Acid-d2
38. Oxalic Acid Dianion
39. Dsstox_cid_5816
40. C00209
41. Dsstox_rid_77935
42. Dsstox_gsid_25816
43. Oxalic Acid Diammonium Salt
44. Wood Bleach
45. Oxaliplatin Related Compound A
46. Cas-144-62-7
47. Oxd
48. C2h2o4
49. Nsc115893
50. Einecs 205-634-3
51. Ethandisaeure
52. Ethanedionate
53. Oxagel
54. Unii-9e7r5l6h31
55. 2dua
56. 2hwg
57. H2ox
58. Anhydrous Oxalic Acid
59. Ethane-1,2-dioate
60. Oxalic Acid, 98%
61. Oxalic Acid (8ci)
62. Oxalic Acid 2 Hydrate
63. Oxalic Acid, Anhydrous
64. Oxalic Acid 2-hydrate
65. 1o4n
66. 1t5a
67. Oxalate Standard For Ic
68. Wln: Qvvq
69. Ethanedioic Acid (9ci)
70. Oxalic Acid [mi]
71. Oxalic Acid Dihydrate Acs
72. Ultraplast Activate S 52
73. Bmse000106
74. Ec 205-634-3
75. Oxalic Acid Low Ash Grade
76. Oxalic Acid [hsdb]
77. Oxalic Acid [inci]
78. Nciopen2_000770
79. Nciopen2_001022
80. Nciopen2_001042
81. Nciopen2_001202
82. Nciopen2_008831
83. Oxalic Acid [vandf]
84. Tetradecanoic-d27acid
85. 4-02-00-01819 (beilstein Handbook Reference)
86. Oxalic Acid [who-dd]
87. Oxalic Acid Solution, 0.5 M
88. Oxalic Acid, Ar, >=99%
89. Oxalic Acid, Lr, >=98%
90. Chembl146755
91. Dtxsid0025816
92. Oxalic Acid Solution, 0.05 M
93. Oxalic Acid, Analytical Standard
94. Bdbm14674
95. Bis(5-azaspiro[2.5]octan-8-ol)
96. Hy-y0262
97. Nsc62774
98. Oxalicacid,0.1nstandardizedsolution
99. Str01359
100. Zinc6021239
101. Tox21_202122
102. Tox21_303346
103. Bbl003000
104. Bis((2r)-azetidine-2-carbonitrile)
105. S9354
106. Stk379550
107. Akos005449445
108. Oxalic Acid, 5% W/v Aqueous Solution
109. Ccg-266020
110. Db03902
111. Sb40938
112. Sb40959
113. Sb40985
114. Oxalic Acid, 10% W/v Aqueous Solution
115. Oxalic Acid, Reagentplus(r), >=99%
116. Ncgc00249170-01
117. Ncgc00257376-01
118. Ncgc00259671-01
119. Bp-21133
120. Oxalic Acid 10 Microg/ml In Acetonitrile
121. Oxalic Acid, 0.1n Standardized Solution
122. Oxalic Acid, Saj First Grade, >=97.0%
123. Bis(1-(3-methyloxetan-3-yl)ethan-1-amine)
124. Cs-0013716
125. Ft-0657506
126. Oxalic Acid, Vetec(tm) Reagent Grade, 98%
127. Oxaliplatin Impurity A [ep Impurity]
128. Oxaliplatin Related Compound A [usp-rs]
129. Oxalic Acid, Purum, Anhydrous, >=97.0% (rt)
130. Q184832
131. J-007978
132. Oxaliplatin Related Compound A [usp Impurity]
133. F1b1b2d7-c290-4ce6-8550-f25b202afade
134. F2191-0257
135. Oxalic Acid, Puriss. P.a., Anhydrous, >=99.0% (rt)
136. Oxalic Acid, Purified Grade, 99.999% Trace Metals Basis
137. Oxalate Standard For Ic, 1.000 G/l In H2o, Analytical Standard
138. Oxalic Acid Concentrate, 0.1 M (cooh)2 (0.2n), Eluent Concentrate For Ic
139. 48j
1. 6153-56-6
2. Ethanedioic Acid, Dihydrate
3. Oxalic Acid Dihydrate
| Molecular Weight | 90.03 g/mol |
|---|---|
| Molecular Formula | C2H2O4 |
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 89.99530854 g/mol |
| Monoisotopic Mass | 89.99530854 g/mol |
| Topological Polar Surface Area | 74.6 Ų |
| Heavy Atom Count | 6 |
| Formal Charge | 0 |
| Complexity | 71.5 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Ascorbic acid ingestion in high doses is associated with oxalate deposition in tissue in dialysis patients. /Oxalates/
Haddad, L.M., Clinical Management of Poisoning and Drug Overdose. 2nd ed. Philadelphia, PA: W.B. Saunders Co., 1990., p. 702
Reducing Agents
Materials that add an electron to an element or compound, that is, decrease the positiveness of its valence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) (See all compounds classified as Reducing Agents.)
TARTARIC & OXALIC ACIDS ARE EXCRETED IN URINE UNCHANGED.
Parke, D. V. The Biochemistry of Foreign Compounds. Oxford: Pergamon Press, 1968., p. 141
The absorption of (14)C-labelled oxalic acid was studied in Wistar rats, CD-1 mice and NMRI mice. Oxalic acid in solution was given to the animals by gavage either with water alone or with 0.625 g/kg body wt of xylitol. Both xylitol adapted animals and animals not previously exposed to xylitol were used. Adaptation to xylitol diets enhanced the absorption and urinary excretion of the label (oxalic acid) in both strains of mice but not in rats. Earlier studies have indicated a high incidence of bladder calculi in mice but not in rats fed high amounts of xylitol. The results of the present study offer one likely explanation for the increased formation of bladder calculi as a result of over saturation of urine with oxalate.
PMID:3188068 Salminen S et al; Toxicol Lett 44 (1-2): 113-20 (1988)
IN RABBIT, MAJOR END-PRODUCT OF METAB OF (14)C-ETHYLENE GLYCOL IS RESP CARBON DIOXIDE (60% OF DOSE IN 3 DAYS), & METABOLITES EXCRETED IN URINE ARE UNCHANGED ETHYLENE GLYCOL (10%) & OXALIC ACID (0.1%). ... GLYCOLALDEHYDE, GLYCOLLIC ACID & GLYOXYLIC ACID ARE INTERMEDIATES IN CONVERSION TO CARBON DIOXIDE.
Parke, D. V. The Biochemistry of Foreign Compounds. Oxford: Pergamon Press, 1968., p. 214
IN OXIDATIVE METAB OF ETHYLENE GLYCOL IN MAMMALS, SPECIES VARIATIONS OCCUR WHICH EXPLAIN ... DIFFERENCES IN TOXICITY. GLYCOL IS OXIDIZED BY MAJOR PATHWAY INTO CARBON DIOXIDE, & BY MINOR PATHWAY TO ... OXALIC ACID. EXTENT OF FORMATION OF OXALIC ACID IS DEPENDENT ON DOSE LEVEL, BUT HAS ... BEEN SHOWN TO VARY WITH SPECIES ...
Parke, D. V. The Biochemistry of Foreign Compounds. Oxford: Pergamon Press, 1968., p. 118
INITIAL STEPS IN OXIDATION OF ETHYLENE GLYCOL TO DIALDEHYDE (GLYOXAL) & TO GLYOXYLIC ACID SEEM TO BE MEDIATED BY ALC DEHYDROGENASE; DECARBOXYLATION OF GLYOXYLIC ACID YIELDS CARBON DIOXIDE & FORMIC ACID. GLYOXYLIC ACID IS ALSO OXIDIZED TO OXALIC ACID.
Gilman, A.G., L.S.Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 7th ed. New York: Macmillan Publishing Co., Inc., 1985., p. 1637
Piridoxilate is an association of glyoxylic acid and pyridoxine in which pyridoxine is supposed to facilitate in vivo transformation of glyoxylic acid to glycine rather than to oxalic acid. However, it has recently been shown that long term treatment with piridoxilate may result in over production of oxalic acid and in calcium oxalate nephrolithiasis. A patient in whom piridoxilate induced both oxalate nephrolithiasis and chronic oxalate nephropathy with renal insufficiency, an association that has not been previously described, was reported. Therefore, piridoxilate should be added to the list of chemicals responsible for chronic oxalate nephropathy.
PMID:3118272 Vigeral P et al; Nephrol Dial Transplant 2 (4): 275-8 (1987)
Cyclosporin A interferes with oxalate metabolism and, therefore, should be given with utmost caution in patients with primary hyperoxaluria.
PMID:3075154 Drachman R et al; Child Nephrol Urol 9 (1-2): 90-2 (1988)
Metabolically its toxicity is believed due to the capacity of oxalic acid to immobilize calcium and thus upset the calcium-potassium ratio in critical tissues.
American Conference of Governmental Industrial Hygienists. Documentation of the Threshold Limit Values and Biological Exposure Indices. 5th ed. Cincinnati, OH: American Conference of Governmental Industrial Hygienists, 1986., p. 451
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Topical
Co-Processed Excipients
Coating Systems & Additives
Parenteral
Thickeners and Stabilizers
Granulation
Fillers, Diluents & Binders
Direct Compression
Taste Masking
Emulsifying Agents
Controlled & Modified Release
Surfactant & Foaming Agents
Solubilizers
Film Formers & Plasticizers
Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
95
PharmaCompass offers a list of Oxalic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxalic Acid manufacturer or Oxalic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxalic Acid manufacturer or Oxalic Acid supplier.
PharmaCompass also assists you with knowing the Oxalic Acid API Price utilized in the formulation of products. Oxalic Acid API Price is not always fixed or binding as the Oxalic Acid Price is obtained through a variety of data sources. The Oxalic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 04621_FLUKA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 04621_FLUKA, including repackagers and relabelers. The FDA regulates 04621_FLUKA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 04621_FLUKA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 04621_FLUKA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 04621_FLUKA supplier is an individual or a company that provides 04621_FLUKA active pharmaceutical ingredient (API) or 04621_FLUKA finished formulations upon request. The 04621_FLUKA suppliers may include 04621_FLUKA API manufacturers, exporters, distributors and traders.
click here to find a list of 04621_FLUKA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
04621_FLUKA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 04621_FLUKA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 04621_FLUKA GMP manufacturer or 04621_FLUKA GMP API supplier for your needs.
A 04621_FLUKA CoA (Certificate of Analysis) is a formal document that attests to 04621_FLUKA's compliance with 04621_FLUKA specifications and serves as a tool for batch-level quality control.
04621_FLUKA CoA mostly includes findings from lab analyses of a specific batch. For each 04621_FLUKA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
04621_FLUKA may be tested according to a variety of international standards, such as European Pharmacopoeia (04621_FLUKA EP), 04621_FLUKA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (04621_FLUKA USP).
